ABCB1 and cancer: This in turn suggests that BGJ 398 might be considered as a potent RTKi to enhance cytotoxic activities of anti-cancer agents for ABCB1-overexpresing human malignancies, whereas high levels of ABCB1 in tumor tissues could be further evaluated as a biomarker for treatment selection of BGJ 398 and PTX.